Making a Birth Plan: A Guide for Expectant Parents

Making a Birth Plan: A Guide for Expectant Parents

Childbirth is unpredictable. But expectant parents can ensure their labor-and-delivery experience goes as smoothly as possible by being prepared, knowing their options and creating a written birth plan before baby’s expected arrival. Here, SMH Childbirth Educator Janis Medford, RN, BSN, offers tips and a practical guide for making an effective birth plan.

Tuesday, May 4, 2021
SMH Again Earns Awards for Quality and Safety

SMH Again Earns Awards for Quality and Safety

Sarasota Memorial Hospital continues to lead the region in quality and safety, earning a 5-star rating for overall quality from the federal government and another "A" for patient safety in The Leapfrog Group's hospital report cards.

Thursday, April 29, 2021
Site Planning Begins for Cancer Institute Expansion Phases 3 & 4

Site Planning Begins for Cancer Institute Expansion Phases 3 & 4

The Sarasota County Public Hospital Board this week authorized Sarasota Memorial staff to move forward with preliminary site and design plans for 2 new outpatient oncology facilities: a new, 6-story cancer pavilion on the hospital’s Sarasota campus and a 2-story cancer center on its developing Venice hospital campus.

Wednesday, April 21, 2021
Quinoa Stir Fry | Healthy Cooking with Thrive

Quinoa Stir Fry | Healthy Cooking with Thrive

In this month's Thrive in the Kitchen healthy-cooking demo video, our team shows you how to make Quinoa Stir Fry with Bok Choy. A great vegetarian source of protein and fiber, quinoa is partnered with delicious veggies to boost the immune system, lower blood pressure and help the body break down potential carcinogens.

Monday, April 19, 2021
SMH Joins Drug Study to Reduce Dangerous Inflammation in COVID-19 Patients

SMH Joins Drug Study to Reduce Dangerous Inflammation in COVID-19 Patients

Sarasota Memorial Hospital is one of more than a dozen research sites across the nation participating in the multi-center trial of IC14, an anti-CD14 monoclonal antibody drug that researchers hope will reduce dangerous levels of inflammation in COVID-19 patients. This week, SMH became the first U.S. site to enroll a patient in the phase 2 trial, called the COVID-19 anti-CD14 Treatment Trial (CaTT). 

Thursday, April 15, 2021
RSS
First417418419420422424425426Last